Filing Details

Accession Number:
0001570562-18-000055
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-08 17:49:26
Reporting Period:
2018-06-07
Accepted Time:
2018-06-08 17:49:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1570562 Evolus Inc. EOLS Pharmaceutical Preparations (2834) 461385614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1730037 Kristine Romine 17901 Von Karman Avenue,
Suite 150
Irvine CA 92614
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-07 200 $33.40 1,200 No 4 P Indirect By son
Common Stock Acquisiton 2018-06-08 2,000 $28.05 8,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By son
No 4 P Direct
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose
  2. Due to an inadvertent error, the number of shares owned by the Reporting Person's Son was overstated on a Form 4 filed on June 4, 2018 by 1,000 shares. The previous error has been corrected in the current filing.